Drug Shortage Report for ZOMIG RAPIMELT

Last updated on 2018-12-10 History
Report ID 65698
Drug Identification Number 02243045
Brand name ZOMIG RAPIMELT
Common or Proper name zolmitriptan
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) ZOLMITRIPTAN
Strength(s) 2.5MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 6 tablets
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date 2018-11-12
Actual start date 2018-11-12
Estimated end date 2018-12-10
Actual end date 2018-12-09
Shortage status Resolved
Updated date 2018-12-10
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2018-12-10 French Compare
v14 2018-12-10 English Compare
v13 2018-12-10 French Compare
v12 2018-12-10 English Compare
v11 2018-12-10 French Compare
v10 2018-12-10 English Compare
v9 2018-11-13 English Compare
v8 2018-11-12 French Compare
v7 2018-11-12 English Compare
v6 2018-10-29 French Compare
v5 2018-10-29 English Compare
v4 2018-10-29 French Compare
v3 2018-10-29 English Compare
v2 2018-10-29 French Compare
v1 2018-10-29 English Compare